Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study

Authors: Wahyu Wulaningsih, Karl Michaelsson, Hans Garmo, Niklas Hammar, Ingmar Jungner, Göran Walldius, Mats Lambe, Lars Holmberg, Mieke Van Hemelrijck

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

Observational studies have indicated that high calcium intake may prevent colorectal cancer, but as for randomized trials the results are inconclusive. Meanwhile, limited data on the link between serum calcium and cancer risk is available. We investigated the relation between serum calcium and risk of different gastrointestinal cancers in a prospective study.

Methods

A cohort based on 492,044 subjects with baseline information on calcium (mmol/L) and albumin (g/L) was selected from the Swedish Apolipoprotein MOrtality RISk (AMORIS) study. Multivariable Cox proportional hazard models were used to analyse associations between standardised levels, quartiles and age/sex-specific categories of serum calcium and risk of oesophageal, stomach, colon, rectal cancer and also colorectal cancer combined, while taking into account serum albumin and other comorbidities.

Results

During 12 years of follow-up, we identified 323 incident oesophageal cancers, 782 stomach cancers, 2519 colon cancers, and 1495 rectal cancers. A positive association was found between albumin-adjusted serum calcium and risk of oesophageal [HR: 4.82 (95% CI: 2.07 – 11.19) for high compared to normal age-specific calcium levels] and colon cancer [e.g. HR: 1.07 (95% CI: 1.00 – 1.14) for every SD increase of calcium] as well as colorectal cancer [e.g. HR: 1.06 (95% CI: 1.02-1.11) for every SD increase of calcium] in women. In men there were similar but weaker non-statistically significant trends.

Conclusion

The positive relation between serum calcium, oesophageal cancer and colorectal cancer calls for further studies including calcium regulators to evaluate whether there is a true link between calcium metabolism and development of gastrointestinal cancer.
Literature
1.
go back to reference Lamprecht SA, Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer. 2003, 3 (8): 601-614. Research Support, U.S. Gov’t, P.H.S. ReviewCrossRefPubMed Lamprecht SA, Lipkin M: Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms. Nat Rev Cancer. 2003, 3 (8): 601-614. Research Support, U.S. Gov’t, P.H.S. ReviewCrossRefPubMed
2.
go back to reference Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, et al: Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J Nutr. 2008, 138 (9): 1658-1663. Research Support, N.I.H., ExtramuralPubMed Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, et al: Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice. J Nutr. 2008, 138 (9): 1658-1663. Research Support, N.I.H., ExtramuralPubMed
3.
go back to reference Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, et al: Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004, 96 (13): 1015-1022. 10.1093/jnci/djh185. Meta-Analysis Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.SCrossRefPubMed Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, et al: Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst. 2004, 96 (13): 1015-1022. 10.1093/jnci/djh185. Meta-Analysis Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.SCrossRefPubMed
4.
go back to reference Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O’Sullivan MJ, et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006, 354 (7): 684-696. 10.1056/NEJMoa055222.CrossRefPubMed Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O’Sullivan MJ, et al: Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006, 354 (7): 684-696. 10.1056/NEJMoa055222.CrossRefPubMed
5.
go back to reference Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010, 5 (Suppl 1): S23-S30. Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed Peacock M: Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010, 5 (Suppl 1): S23-S30. Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed
6.
go back to reference Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis. 2010, 213 (1): 299-305. 10.1016/j.atherosclerosis.2010.08.049. Research Support, Non-U.S. Gov’tCrossRefPubMed Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis. 2010, 213 (1): 299-305. 10.1016/j.atherosclerosis.2010.08.049. Research Support, Non-U.S. Gov’tCrossRefPubMed
7.
go back to reference Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR: Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women’s health initiative limited access dataset and meta-analysis. BMJ. 2011, 342: d2040-10.1136/bmj.d2040. Meta-Analysis Research Support, Non-U.S. Gov’t ReviewCrossRefPubMedPubMedCentral Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR: Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the women’s health initiative limited access dataset and meta-analysis. BMJ. 2011, 342: d2040-10.1136/bmj.d2040. Meta-Analysis Research Support, Non-U.S. Gov’t ReviewCrossRefPubMedPubMedCentral
8.
go back to reference Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E: Apolipoprotein B and a-I values in 147576 swedish males and females, standardized according to the world health organization-international federation of clinical chemistry first international reference materials. Clin Chem. 1998, 44 (8 Pt 1): 1641-1649. Comparative Study Research Support, Non-U.S. Gov’tPubMed Jungner I, Marcovina SM, Walldius G, Holme I, Kolar W, Steiner E: Apolipoprotein B and a-I values in 147576 swedish males and females, standardized according to the world health organization-international federation of clinical chemistry first international reference materials. Clin Chem. 1998, 44 (8 Pt 1): 1641-1649. Comparative Study Research Support, Non-U.S. Gov’tPubMed
9.
go back to reference Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001, 358 (9298): 2026-2033. 10.1016/S0140-6736(01)07098-2.CrossRefPubMed Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E: High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001, 358 (9298): 2026-2033. 10.1016/S0140-6736(01)07098-2.CrossRefPubMed
10.
go back to reference Holme I, Aastveit AH, Jungner I, Walldius G: Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2008, 264 (1): 30-38. 10.1111/j.1365-2796.2008.01925.x.CrossRefPubMed Holme I, Aastveit AH, Jungner I, Walldius G: Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2008, 264 (1): 30-38. 10.1111/j.1365-2796.2008.01925.x.CrossRefPubMed
11.
go back to reference Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009, 265 (2): 275-287. 10.1111/j.1365-2796.2008.02016.x. Research Support, Non-U.S. Gov’tCrossRefPubMed Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Relationships between lipoprotein components and risk of ischaemic and haemorrhagic stroke in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009, 265 (2): 275-287. 10.1111/j.1365-2796.2008.02016.x. Research Support, Non-U.S. Gov’tCrossRefPubMed
12.
go back to reference Walldius G, Jungner I, Kolar W, Holme I, Steiner E: High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl. 1992, 4: 35-42.PubMed Walldius G, Jungner I, Kolar W, Holme I, Steiner E: High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein related MOrtality RISk) study. Blood Press Suppl. 1992, 4: 35-42.PubMed
13.
go back to reference Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, et al: Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control. 2010, 21: 1657-1667. 10.1007/s10552-010-9594-6.CrossRefPubMed Van Hemelrijck M, Garmo H, Binda E, Hayday A, Karagiannis SN, Hammar N, et al: Immunoglobulin E and cancer: a meta-analysis and a large Swedish cohort study. Cancer Causes Control. 2010, 21: 1657-1667. 10.1007/s10552-010-9594-6.CrossRefPubMed
14.
go back to reference Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, et al: Prostate cancer risk in the Swedish AMORIS study: the interplay between triglycerides, total cholesterol, and glucose. Cancer. 2010, in press Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, et al: Prostate cancer risk in the Swedish AMORIS study: the interplay between triglycerides, total cholesterol, and glucose. Cancer. 2010, in press
16.
go back to reference Bringhurst F, Demay M, Krane S, Kronenberg H, et al: Bone and mineral metabolism in health and disease. Harrrion’s Prinicples of Internal Medicine. Edited by: Fauci A, Longo D, Kasper D, Braunwald E, Jameson J, Loscalzo J. 2008, New York: McGraw-Hill Bringhurst F, Demay M, Krane S, Kronenberg H, et al: Bone and mineral metabolism in health and disease. Harrrion’s Prinicples of Internal Medicine. Edited by: Fauci A, Longo D, Kasper D, Braunwald E, Jameson J, Loscalzo J. 2008, New York: McGraw-Hill
17.
go back to reference Jungner I, Walldius G, Holme I, Kolar W, Steiner E: Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int J Clin Lab Res. 1992, 21 (3): 247-255.CrossRefPubMed Jungner I, Walldius G, Holme I, Kolar W, Steiner E: Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43,000 Swedish males and females. Int J Clin Lab Res. 1992, 21 (3): 247-255.CrossRefPubMed
18.
go back to reference Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J, et al: Serum calcium and the risk of prostate cancer. Cancer Causes Control. 2009, 20 (7): 1205-1214. 10.1007/s10552-009-9342-y.CrossRefPubMed Halthur C, Johansson AL, Almquist M, Malm J, Gronberg H, Manjer J, et al: Serum calcium and the risk of prostate cancer. Cancer Causes Control. 2009, 20 (7): 1205-1214. 10.1007/s10552-009-9342-y.CrossRefPubMed
19.
go back to reference Pintilie M: Competing risks : a practical perspective. Chichester, England. 2006, Hoboken, NJ: John Wiley & SonsCrossRef Pintilie M: Competing risks : a practical perspective. Chichester, England. 2006, Hoboken, NJ: John Wiley & SonsCrossRef
20.
go back to reference Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M: Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2009, 30 (1): 88-92. Research Support, N.I.H., ExtramuralCrossRefPubMed Newmark HL, Yang K, Kurihara N, Fan K, Augenlicht LH, Lipkin M: Western-style diet-induced colonic tumors and their modulation by calcium and vitamin D in C57Bl/6 mice: a preclinical model for human sporadic colon cancer. Carcinogenesis. 2009, 30 (1): 88-92. Research Support, N.I.H., ExtramuralCrossRefPubMed
21.
go back to reference Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, et al: A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis. 2001, 22 (11): 1871-1875. 10.1093/carcin/22.11.1871. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.SCrossRefPubMed Newmark HL, Yang K, Lipkin M, Kopelovich L, Liu Y, Fan K, et al: A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice. Carcinogenesis. 2001, 22 (11): 1871-1875. 10.1093/carcin/22.11.1871. Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.SCrossRefPubMed
22.
go back to reference Jacobs ET, Jurutka PW, Martinez ME, Alberts DS: Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of action. Cancer Prev Res (Phila). 2009, 2 (3): 197-199. 10.1158/1940-6207.CAPR-09-0019. CommentCrossRef Jacobs ET, Jurutka PW, Martinez ME, Alberts DS: Vitamin D, calcium, and colorectal neoplasia: new insights on mechanisms of action. Cancer Prev Res (Phila). 2009, 2 (3): 197-199. 10.1158/1940-6207.CAPR-09-0019. CommentCrossRef
23.
go back to reference Whitfield JF: Calcium, calcium-sensing receptor and colon cancer. Cancer Lett. 2009, 275 (1): 9-16. 10.1016/j.canlet.2008.07.001. ReviewCrossRefPubMed Whitfield JF: Calcium, calcium-sensing receptor and colon cancer. Cancer Lett. 2009, 275 (1): 9-16. 10.1016/j.canlet.2008.07.001. ReviewCrossRefPubMed
24.
go back to reference Cullen PJ, Lockyer PJ: Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol. 2002, 3 (5): 339-348. 10.1038/nrm808. Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed Cullen PJ, Lockyer PJ: Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol. 2002, 3 (5): 339-348. 10.1038/nrm808. Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed
25.
go back to reference Whitfield JF: The calcium-sensing receptor--a driver of colon cell differentiation. Curr Pharm Biotechnol. 2009, 10 (3): 311-316. 10.2174/138920109787847510. ReviewCrossRefPubMed Whitfield JF: The calcium-sensing receptor--a driver of colon cell differentiation. Curr Pharm Biotechnol. 2009, 10 (3): 311-316. 10.2174/138920109787847510. ReviewCrossRefPubMed
26.
go back to reference Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL: Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002, 94 (6): 437-446. 10.1093/jnci/94.6.437.CrossRefPubMed Wu K, Willett WC, Fuchs CS, Colditz GA, Giovannucci EL: Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst. 2002, 94 (6): 437-446. 10.1093/jnci/94.6.437.CrossRefPubMed
27.
go back to reference Mizoue T, Kimura Y, Toyomura K, Nagano J, Kono S, Mibu R, et al: Calcium, dairy foods, vitamin D, and colorectal cancer risk: the fukuoka colorectal cancer study. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2800-2807. 10.1158/1055-9965.EPI-08-0369. Research Support, Non-U.S. Gov’tCrossRefPubMed Mizoue T, Kimura Y, Toyomura K, Nagano J, Kono S, Mibu R, et al: Calcium, dairy foods, vitamin D, and colorectal cancer risk: the fukuoka colorectal cancer study. Cancer Epidemiol Biomarkers Prev. 2008, 17 (10): 2800-2807. 10.1158/1055-9965.EPI-08-0369. Research Support, Non-U.S. Gov’tCrossRefPubMed
28.
go back to reference Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS: Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005, 14 (2): 525-528. 10.1158/1055-9965.EPI-04-0466. Research Support, U.S. Gov’t, P.H.SCrossRefPubMed Miller EA, Keku TO, Satia JA, Martin CF, Galanko JA, Sandler RS: Calcium, vitamin D, and apoptosis in the rectal epithelium. Cancer Epidemiol Biomarkers Prev. 2005, 14 (2): 525-528. 10.1158/1055-9965.EPI-04-0466. Research Support, U.S. Gov’t, P.H.SCrossRefPubMed
29.
go back to reference Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, et al: Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009, 2 (3): 213-223. 10.1158/1940-6207.CAPR-08-0157. Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’tCrossRef Fedirko V, Bostick RM, Flanders WD, Long Q, Shaukat A, Rutherford RE, et al: Effects of vitamin D and calcium supplementation on markers of apoptosis in normal colon mucosa: a randomized, double-blind, placebo-controlled clinical trial. Cancer Prev Res (Phila). 2009, 2 (3): 213-223. 10.1158/1940-6207.CAPR-08-0157. Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’tCrossRef
30.
go back to reference Carroll C, Cooper K, Papaioannou D, Hind D, Pilgrim H, Tappenden P: Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther. 2010, 32 (5): 789-803. 10.1016/j.clinthera.2010.04.024. Meta-Analysis Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed Carroll C, Cooper K, Papaioannou D, Hind D, Pilgrim H, Tappenden P: Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther. 2010, 32 (5): 789-803. 10.1016/j.clinthera.2010.04.024. Meta-Analysis Research Support, Non-U.S. Gov’t ReviewCrossRefPubMed
31.
go back to reference Mulholland HG, Murray LJ, Anderson LA, Cantwell MM: Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br J Nutr. 2011, 106 (5): 732-741. 10.1017/S0007114511000742. Research Support, Non-U.S. Gov’tCrossRefPubMed Mulholland HG, Murray LJ, Anderson LA, Cantwell MM: Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions. Br J Nutr. 2011, 106 (5): 732-741. 10.1017/S0007114511000742. Research Support, Non-U.S. Gov’tCrossRefPubMed
32.
go back to reference Kuro-o M: Klotho in health and disease. Curr Opin Nephrol Hypertens. 2012, 21: 362-368. 10.1097/MNH.0b013e32835422ad.CrossRefPubMed Kuro-o M: Klotho in health and disease. Curr Opin Nephrol Hypertens. 2012, 21: 362-368. 10.1097/MNH.0b013e32835422ad.CrossRefPubMed
33.
go back to reference Giovannucci E: Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt). 2003, 12 (2): 173-182. 10.1089/154099903321576574. ReviewCrossRef Giovannucci E: Diet, body weight, and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt). 2003, 12 (2): 173-182. 10.1089/154099903321576574. ReviewCrossRef
34.
go back to reference Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Ostergren J: Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). Renal insufficiency, mortality and myocardial infarction. Edited by: Holzmann M. 2008, Stockholm: Karolinska Institutet Holzmann M, Jungner I, Walldius G, Ivert I, Nordqvist T, Ostergren J: Apolipoproteins B and A-I, standard lipid measures and incidence of myocardial infarction in men and women, with or without chronic kidney disease. Study IV in Thesis for doctorial degree (PhD). Renal insufficiency, mortality and myocardial infarction. Edited by: Holzmann M. 2008, Stockholm: Karolinska Institutet
Metadata
Title
Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
Authors
Wahyu Wulaningsih
Karl Michaelsson
Hans Garmo
Niklas Hammar
Ingmar Jungner
Göran Walldius
Mats Lambe
Lars Holmberg
Mieke Van Hemelrijck
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-663

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue